Real time PCR molecular microbiology - mrsa cost-per-test BPA
Ended Awarded Last action
- Contract number
- 36C26223N0894
- Awardee
-
Cepheid UEI W6HQTMWB9Q28
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,227,344
Award facts
- Contract value 50% obligated
- $2,437,820.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Sunnyvale, CA 94089, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$59 | |
| Funding Only Action | -$24,329 | |
| Exercise an Option | $822,048 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $388,438 | |
| Supplemental Agreement for work within scope | -$10 | |
| Original award | $1,251,732 |
About this award
This Blanket Purchase Agreement (BPA) Call for real-time polymerase chain reaction (PCR) molecular microbiology testing for methicillin-resistant Staphylococcus aureus (MRSA) was awarded to Cepheid Inc. on September 8, 2023, with a ceiling value of $2.44M and completion date of March 27, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation and will be performed in Sunnyvale, California. Cepheid, a leading manufacturer of advanced molecular diagnostic systems and reagents, will provide cost-per-test MRSA detection services through its GeneXpert diagnostic platform to support clinical laboratory operations within the Department of Veterans Affairs, specifically Veterans Integrated Service Network 22 (VISN 22).
This award is part of Cepheid's extensive federal contract portfolio with the VA, which includes two significant indefinite delivery contracts: a $6.74M single-award IDC with VISN 17 (extending through December 28, 2029) for diagnostic reagents and test kits, and a substantially larger $32.8M single-award IDC with VISN 6 (extending through September 30, 2030) for molecular diagnostic testing system reagents and assays. Cepheid's established position as a primary federal supplier of diagnostic solutions reflects the VA's reliance on the company's GeneXpert platform for infectious disease testing across its network of medical centers, supporting critical clinical laboratory capabilities for patient care.
Quick answers
Who was awarded contract 36C26223N0894?
36C26223N0894 was awarded to Cepheid by Veterans Integrated Service Network 22 (Veterans Health Administration) on September 8, 2023.
How much is contract 36C26223N0894 worth?
The government has obligated $1,227,344 on 36C26223N0894. Its current value, with exercised options, is $2,437,820.
Is contract 36C26223N0894 an order under another contract?
Yes. 36C26223N0894 is a BPA call under 36C26218A0032, a blanket purchase agreement.
Was contract 36C26223N0894 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award